Polyp-adjacent biopsies no longer required in inflammatory bowel disease Response

被引：0
|
作者：
Cleveland, Noa Krugliak [1 ]
Rubin, David T. [1 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA
来源：
GASTROINTESTINAL ENDOSCOPY | 2018年 / 88卷 / 04期
关键词：
D O I：
10.1016/j.gie.2018.06.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：783 / 784
页数：2
相关论文
共 50 条
  • [41] Megacolon in inflammatory bowel disease: response to infliximab
    Nunez-Ortiz, Andrea
    Trigo-Salado, Claudio
    Dolores de la Cruz-Ramirez, Maria
    Luis Marquez-Galan, Jose
    Manuel Herrera-Justiniano, Jose
    Leo-Carnerero, Eduardo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (02) : 90 - 93
  • [42] Inflammatory bowel disease in Asia: response to therapy
    Ouyang, Q.
    Zhang, H.
    Wang, Y.
    Chen, X.
    EMERGING ISSUES IN INFLAMMATORY BOWEL DISEASES, 2006, 151 : 19 - 21
  • [43] Response to "Histopathological Mimics of Inflammatory Bowel Disease"
    Hokama, Akira
    Omija, Hidenao
    Kishimoto, Kazuto
    Kinjo, Tatsuya
    Kinjo, Tetsu
    Fujita, Jiro
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (01) : E5 - E6
  • [44] Symptomatic response to omeprazole in inflammatory bowel disease
    Guslandi, M
    Tittobello, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1996, 22 (02) : 159 - 160
  • [45] Isotretinoin and Risk of Inflammatory Bowel Disease Response
    Racine, Antoine
    Boutron-Ruault, Marie-Christine
    Carbonnel, Franck
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09): : 1494 - 1495
  • [46] Statins and the Risk of Inflammatory Bowel Disease Response
    Ungaro, Ryan
    Chang, Helena L.
    Colombel, Jean-Frederic
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12): : 1851 - 1852
  • [47] Serrated lesions in inflammatory bowel disease Response
    Parian, Alyssa
    Lazarev, Mark
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (02) : 461 - 462
  • [48] Predicting Response to Vedolizumab in Inflammatory Bowel Disease
    Meserve, Joseph
    Dulai, Parambir
    FRONTIERS IN MEDICINE, 2020, 7
  • [49] Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?
    Goren, Idan
    Yanai, Henit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (02) : 244 - 245
  • [50] Elevated Faecal Calprotectin Does Not Differentiate Between Inflammatory Bowel Disease and a Juvenile Polyp
    Zijlstra, Marieke
    Pluimakers, Vincent
    Nikkels, Peter
    Wolters, Victorien
    Houwen, Roderick
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (02): : E22 - E23
12345